OVID
Price:
$0.9663
Market Cap:
$68.62M
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder. The company has license and collabo...[Read more]
Industry
Biotechnology
IPO Date
2017-05-05
Stock Exchange
NASDAQ
Ticker
OVID
According to Ovid Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -39.24%. This represents a change of 281.34% compared to the average of -10.29% of the last 4 quarters.
The mean historical ROE of Ovid Therapeutics Inc. over the last ten years is -58.56%. The current -39.24% ROE has changed -32.99% with respect to the historical average. Over the past ten years (40 quarters), OVID's ROE was at its highest in in the March 2023 quarter at 1.26%. The ROE was at its lowest in in the March 2017 quarter at -80.87%.
Average
-58.56%
Median
-52.54%
Minimum
-185.02%
Maximum
68.34%
Discovering the peaks and valleys of Ovid Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 135.18%
Maximum Annual ROE = 68.34%
Minimum Annual Increase = -156.87%
Minimum Annual ROE = -185.02%
Year | ROE | Change |
---|---|---|
2023 | -59.61% | 53.38% |
2022 | -38.87% | -156.87% |
2021 | 68.34% | -136.93% |
2020 | -185.02% | 118.64% |
2019 | -84.63% | -36.82% |
2018 | -133.95% | 72.46% |
2017 | -77.67% | 70.82% |
2016 | -45.47% | 135.18% |
2015 | -19.33% | 104.99% |
The current ROE of Ovid Therapeutics Inc. (OVID) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.05%
5-year avg
-59.96%
10-year avg
-58.56%
Ovid Therapeutics Inc.’s ROE is greater than CytomX Therapeutics, Inc. (-41.34%), less than Spero Therapeutics, Inc. (3.36%), greater than Neoleukin Therapeutics, Inc. (-8.54%), greater than Instil Bio, Inc. (-37.44%), greater than NextCure, Inc. (-62.50%), greater than Assembly Biosciences, Inc. (-121.46%), greater than Achilles Therapeutics plc (-54.57%), greater than Nuvation Bio Inc. (-108.68%), less than Connect Biopharma Holdings Limited (7.21%),
Company | ROE | Market cap |
---|---|---|
-41.34% | $83.74M | |
3.36% | $51.11M | |
-8.54% | $8.20M | |
-37.44% | $142.85M | |
-62.50% | $24.31M | |
-121.46% | $93.56M | |
-54.57% | $46.85M | |
-108.68% | $949.12M | |
7.21% | $55.03M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ovid Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ovid Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ovid Therapeutics Inc.'s ROE?
How is the ROE calculated for Ovid Therapeutics Inc. (OVID)?
What is the highest ROE for Ovid Therapeutics Inc. (OVID)?
What is the 3-year average ROE for Ovid Therapeutics Inc. (OVID)?
What is the 5-year average ROE for Ovid Therapeutics Inc. (OVID)?
How does the current ROE for Ovid Therapeutics Inc. (OVID) compare to its historical average?